Menu

Huge Gender Disparity in Cancer Research Funding in U.K.

Men received both more and larger grants than women did, ending up with three times as much funding on average.

May 16, 2018
Shawna Williams

ISTOCK, TSVIBRAVBetween 2000 and 2013, women received just 31 percent of the number of cancer research grants awarded in the U.K., and 22 percent of the total funds to investigate cancer, according to an analysis published Tuesday (May 14) in BMJ Open. “We would strongly urge policy-makers, funders and the academic and scientific community to investigate the factors leading to our observed differences and seek to ensure that women are appropriately supported in scientific endeavour,” the authors write in the paper.

The analysis examined data on both public and philanthropic grants given to support cancer research in the U.K. Male PIs were awarded 69 percent of the grants, and their grants were on average 1.3 times as large as those given to women, so that they received 78 percent of the total money allocated.

“The significant concern following such an apparent gender imbalance is the possibility of bias or inequality against women researchers, which must be addressed,” coauthor Mahiben Maruthappu tells Medscape Medical News.

Gender disparities in the sciences are well-established. For example, female PhD students tend to publish less than their male counterparts and women are less likely to have opportunities to speak at conferences or to be successful when applying for patents. The authors of the paper note that “just one in five countries worldwide has achieved gender parity in scientific research (defined as when 45% to 55% of researchers are women).”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.